The Efficacy of Drug-Coated Balloon for Acute Coronary Syndrome
Background. Percutaneous coronary intervention using a drug-eluting stent (DES) is a common therapeutic option for acute coronary syndrome (ACS). However, stent-associated complications, such as bleeding associated with dual antiplatelet therapy, in-stent restenosis, stent thrombosis, and neoatheros...
Main Authors: | Hirokazu Naganawa, Akira Ito, Shinrou Saiki, Daisuke Nishi, Shinichi Takamatsu, Yoshihisa Ito, Takeshi Suzuki |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2023-01-01
|
Series: | Cardiology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2023/4594818 |
Similar Items
-
Efficacy of the hemostatic device VasoSTAT and the study of hemostatic factor
by: Hirokazu Naganawa, et al.
Published: (2021-11-01) -
Safety and Efficacy of Drug-Coated Balloons in Patients with Acute Coronary Syndromes and Vulnerable Plaque
by: Yu-Bin Zhang BS, et al.
Published: (2022-10-01) -
Efficacy of Low-Pressure Inflation of Oversized Drug-Coated Balloon for Coronary Artery Disease
by: Katsumi Ueno, et al.
Published: (2020-01-01) -
Drug-Coated Balloon in Primary Percutaneous Coronary Intervention
by: Hui Zhao, et al.
Published: (2023-01-01) -
Efficacy and risks of drug-coated balloon treatment for coronary artery disease: A meta-analysis
by: Xinghua Bai, et al.
Published: (2023-11-01)